57 search results for: pediatric

Missing material
Content temporarily unavailable
Pediatric EoE Disease Burden Infographic

Learn about pediatric EoE disease burden and why early identification is key for pediatric patients with EoE

Missing material
Content temporarily unavailable
Keeping an Eye on Pediatric EoE

Global experts Prof. Arjan Bredenoord and Drs. Ikuo Hirano, Kathryn Peterson, and Evan Dellon discuss identification and assessment of pediatric EoE.

Missing material
Content temporarily unavailable
Explore the Global Burden of Pediatric AD (PEDISTAD)

This interactive tool allows you to explore the global burden of AD in pediatric patients <12 years from the PEDISTAD Study.

Missing material
Content temporarily unavailable
Eosinophilic Esophagitis (EoE) Pediatric Interactive Patient Case

Experience a pediatric patient's journey from infancy to adolescence with guideline-based learnings on EoE diagnosis, treatment, and long-term care.

Missing material
Content temporarily unavailable
ADVENT at ESPGHAN | Shedding Light on Pediatric Eosinophilic Esophagitis: Timely Identification and Management

Join global experts Prof. Salvatore Oliva and Dr. Dhandapani Ashok for an educational symposium at ESPGHAN, as they discuss the burden and impact of underlying type 2 inflammation in eosinophilic esophagitis (EoE), and the importance of early diagnosis and management in pediatric patients.

Missing material
Content temporarily unavailable
Pediatric Asthma Patient Case Tool: Ash

Review a patient case to learn more about identifying uncontrolled asthma and type 2 inflammation in pediatric patients

Missing material
Content temporarily unavailable
ADVENT at EAACI PAAM 2025

Join Sanofi and Regeneron for ​an educational symposium on type 2 inflammation processes underlying pediatric asthma, atopic dermatitis,​ and eosinophilic esophagitis.

Missing material
Content temporarily unavailable
Unlocking Better Outcomes: Strategies for Early Diagnosis and Effective Management in Pediatric EoE Patients

Pediatric gastroenterology experts Dr Carolina Gutiérrez Junquera and Dr Christos Tzivinikos where they discuss the importance of early identification and management of pediatric EoE to improve long-term outcomes. They highlight clinical data and discuss their practical experiences with pediatric EoE, including their perspectives on co-occurring type 2 inflammatory diseases, the chronic nature of EoE, and the future of EoE research and therapeutic development.

Missing material
Content temporarily unavailable
ADVENT at ESPGHAN 2025 | Unlocking Better Outcomes: Strategies for Early Diagnosis and Effective Management in Pediatric EoE Patients

In support of World Eosinophilic Esophagitis Day, this ADVENT symposium features pediatric gastroenterology experts Dr Carolina Gutiérrez Junquera and Dr Christos Tzivinikos where they discuss the importance of early identification and management of pediatric EoE to improve long-term outcomes. They highlight clinical data and discuss their practical experiences with pediatric EoE, including their perspectives on co-occurring type 2 inflammatory diseases, the chronic nature of EoE, and the future of EoE research and therapeutic development.

Missing material
Content temporarily unavailable
ADVENT at ESPGHAN 2026 | Pediatric EoE: An Interactive Learning Symposium

Join leading experts in pediatric eosinophilic esophagitis (EoE), Professors Salvatore Oliva, MD, PhD, and André Hörning, MD, as they explore the multifaceted journey of pediatric patients with EoE through a hypothetical patient case, navigating real-world challenges in managing EoE.

Missing material
Content temporarily unavailable
The PEDISTAD Survey: Assessing the Burden of Atopic Dermatitis in the Global Pediatric Population

An interactive tool used to explore the global burden of atopic dermatitis in children and adolescents.

Missing material
Content temporarily unavailable
KOL Video Interview – Dr Amy Paller

In this exclusive video interview, Dr Amy Paller discusses two topics: 1) The importance of CCL17 (TARC) as a biomarker in pediatric patients with AD, and 2) How IL-4 and IL-13 contribute to skin barrier dysfunction in AD.